Trevi Therapeutics Inc is a biopharmaceutical company focused on developing innovative therapies for chronic conditions with high unmet medical needs
The company's primary focus is on utilizing its proprietary formulation technology to create treatments for neurological and chronic pain disorders, including pruritus associated with specific dermatological conditions. Through advanced research and clinical trials, Trevi aims to bring new, effective solutions to patients suffering from debilitating symptoms, thereby improving their quality of life.
Companies Reporting Before The Bell • UP Fintech Holding (NASDAQTIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million.
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQIDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSETAK) is likely to report earnings for its fourth quarter. • Exela Technologies NASDAQ:XELANASDAQXELA)
Gainers Glory Star New Media Group Holdings Limited (NASDAQGSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional investors at $2.48 per share.
Companies Reporting Before The Bell • KVH Industries (NASDAQKVHI) is projected to report quarterly earnings at $0.03 per share on revenue of $34.29 million.
